NO972046D0 - Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike - Google Patents

Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike

Info

Publication number
NO972046D0
NO972046D0 NO972046A NO972046A NO972046D0 NO 972046 D0 NO972046 D0 NO 972046D0 NO 972046 A NO972046 A NO 972046A NO 972046 A NO972046 A NO 972046A NO 972046 D0 NO972046 D0 NO 972046D0
Authority
NO
Norway
Prior art keywords
allogeneic
antibodies
diagnosis
therapy
determining
Prior art date
Application number
NO972046A
Other languages
English (en)
Other versions
NO972046L (no
Inventor
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO972046L publication Critical patent/NO972046L/no
Publication of NO972046D0 publication Critical patent/NO972046D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO972046A 1994-11-04 1997-05-02 Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike NO972046D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002238A IT1276860B1 (it) 1994-11-04 1994-11-04 Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
PCT/EP1995/004239 WO1996014340A1 (en) 1994-11-04 1995-10-30 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Publications (2)

Publication Number Publication Date
NO972046L NO972046L (no) 1997-05-02
NO972046D0 true NO972046D0 (no) 1997-05-02

Family

ID=11369803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972046A NO972046D0 (no) 1994-11-04 1997-05-02 Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike

Country Status (26)

Country Link
EP (1) EP0789716B1 (no)
JP (1) JPH10508591A (no)
KR (1) KR100426029B1 (no)
CN (1) CN1046737C (no)
AR (1) AR002243A1 (no)
AT (1) ATE192166T1 (no)
AU (1) AU690756B2 (no)
BR (1) BR9509556A (no)
CA (1) CA2204380A1 (no)
CZ (1) CZ288322B6 (no)
DE (1) DE69516534T2 (no)
DK (1) DK0789716T3 (no)
ES (1) ES2147617T3 (no)
FI (1) FI971879A (no)
GR (1) GR3033956T3 (no)
HU (1) HUT76880A (no)
IL (1) IL115862A (no)
IT (1) IT1276860B1 (no)
NO (1) NO972046D0 (no)
NZ (1) NZ295171A (no)
PL (1) PL181115B1 (no)
PT (1) PT789716E (no)
RU (1) RU2160445C2 (no)
TR (1) TR199501353A2 (no)
WO (1) WO1996014340A1 (no)
ZA (1) ZA959255B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283634B1 (it) * 1996-05-10 1998-04-23 Zetesis Spa Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
IT201900022203A1 (it) * 2019-11-26 2021-05-26 Cusani Alberto Bartorelli Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.

Also Published As

Publication number Publication date
BR9509556A (pt) 1997-09-16
ES2147617T3 (es) 2000-09-16
KR970707161A (ko) 1997-12-01
ITMI942238A1 (it) 1996-05-04
CN1166838A (zh) 1997-12-03
GR3033956T3 (en) 2000-11-30
IL115862A (en) 2001-06-14
NO972046L (no) 1997-05-02
DE69516534T2 (de) 2000-11-30
EP0789716A1 (en) 1997-08-20
JPH10508591A (ja) 1998-08-25
ATE192166T1 (de) 2000-05-15
TR199501353A2 (tr) 1996-06-21
PL319878A1 (en) 1997-09-01
PL181115B1 (pl) 2001-05-31
AU690756B2 (en) 1998-04-30
RU2160445C2 (ru) 2000-12-10
FI971879A0 (fi) 1997-05-02
CA2204380A1 (en) 1996-05-17
NZ295171A (en) 1998-07-28
KR100426029B1 (ko) 2004-07-31
EP0789716B1 (en) 2000-04-26
ZA959255B (en) 1996-05-29
CZ288322B6 (en) 2001-05-16
WO1996014340A1 (en) 1996-05-17
DK0789716T3 (da) 2000-10-09
DE69516534D1 (de) 2000-05-31
MX9703191A (es) 1997-07-31
PT789716E (pt) 2000-09-29
CZ131497A3 (en) 1997-12-17
FI971879A (fi) 1997-06-24
IT1276860B1 (it) 1997-11-03
HUT76880A (en) 1997-12-29
CN1046737C (zh) 1999-11-24
AR002243A1 (es) 1998-03-11
ITMI942238A0 (it) 1994-11-04
IL115862A0 (en) 1996-01-31
AU3845395A (en) 1996-05-31

Similar Documents

Publication Publication Date Title
EE9700030A (et) Kehakaalu modulaatorid, neile vastavad nukleiinhapped ja valgud ning nende kasutamine diagnostikas ja teraapias
NO973447L (no) Monoklonale antistoffer som er spesifikke for forskjellige epitoper i human-gp 39, og fremgangsmåter for deres anvendelse i diagnose og terapi
ES529048A0 (es) Perfeccionamientos en un sistema de representacion por ultrasonidos
PT87688A (pt) Hybrid protein c and method for its preparation
FI962844A0 (fi) T-soluantigeenireseptorin V-alueen proteiineja ja menetelmiä niiden valmistamiseksi
SE9604815D0 (sv) A metod of diagnosis
DE3865034D1 (de) Ultraschall-untersuchungsgeraet.
DE68917273D1 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
NO972046D0 (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
ES529047A0 (es) Perfeccionamientos en un sistema de representacion por ultrasonidos
AU591579B2 (en) Antibodies for use in determining human glycoalbumin
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
IT1274006B (it) Saggio immunologico per analiti in campioni, che utilizza agenti alchilanti
IT1279079B1 (it) Vibratore,in particolare per laboratorio dentistico
VAILATI Coleotteri Catopidi e Colonidi della provincia di Brescia
SE8705082D0 (sv) Angmotorsystem i forsta hand for drivorgan
ZA876206B (en) Antibodies for use in determining human glycoalbumin
KR890011591U (ko) 플로피 디스크 드라이브의 디스크 안착장치
ITRM920717A0 (it) Corredo diagnostico immunologico e metodo per la sua utilizzazione.
SE8600543D0 (sv) Diagnostiskt test for detektering av antikroppar i kroppsvetskor
SE9503044D0 (sv) Antibodies for use in cancer therapy and diagnosis
BR6300998U (pt) Disposicao introduzida em sistema para coleta de sangue
NO863774D0 (no) Boelgedemper med flyte-element innebygget i konstruksjon.
IT8811541V0 (it) Scheda semplificata di diagnosi edi trattamento in pratica odontostomatologica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application